Article
Complete biosynthesis of QS-21 in engineered yeast
8 May 2024
Abstract excerpt
Abstract QS-21 is a potent vaccine adjuvant and remains the only saponin-based adjuvant that has been clinically approved for use in humans 1,2 . However, owing to the complex structure of QS-21, its availability is limited. Today, the supply depends on laborious extraction from the Chilean soapbark tree or on low-yielding total chemical synthesis 3,4 . Here we demonstrate the complete biosynthesis of QS-21 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
